A call for Expression of Interest to participate in EUnetHTA JA3 Early Dialogues has now been published.
A call for Expression of Interest to participate in EUnetHTA JA3 Early Dialogues has now been published. It is directed at healthcare product/technology developers and sponsors. Please note, the current call is restricted to pharmaceuticals, but medical devices will soon be added. Once candidates have been selected for the 13-15 EDs, additional applications may be considered for a ‘reserve’ list.
Expression of interest and questions about EUnetHTA EDs should be directed to the WP5 coordinating team at: email@example.com
The Early Dialogues to be performed by EUnetHTA will build on the experience gained from the EDs conducted within EUnetHTA (EUnetHTA JA2 WP7) and the SEED Consortium. The European Medicines Agency, EMA, is invited to participate as observer in all EUnetHTA Early Dialogues on medicinal products.